Topical ronomilast alone or combined with clobetasol ameliorates imiquimod-induced psoriasis in mice
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05655-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Hasnaa Suhail Jasim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Al- Nahrain University, Baghdad, Iraq. hasnaa.s.jasim.ph24@ced.nahrainuniv.edu.iq. Hauptthemen laut MEDLINE: Psoriasis, Phosphodiesterase 4 Inhibitors, Clobetasol, Anti-Inflammatory Agents. Die Arbeit nennt 84 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, Al- Nahrain University, Baghdad, Iraq. hasnaa.s.jasim.ph24@ced.nahrainuniv.edu.iq.
- Department of Pharmacology and Toxicology, College of Pharmacy, Al- Nahrain University, Baghdad, Iraq.
Zitieren
APA
Jasim, H. S., & Hameed, M. F. (2026). Topical ronomilast alone or combined with clobetasol ameliorates imiquimod-induced psoriasis in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05655-5
Vancouver
Jasim HS, Hameed MF. Topical ronomilast alone or combined with clobetasol ameliorates imiquimod-induced psoriasis in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05655-5
BibTeX
@article{Jasim2026,
author = {Jasim, Hasnaa Suhail and Hameed, Mohammed Fareed},
title = {Topical ronomilast alone or combined with clobetasol ameliorates imiquimod-induced psoriasis in mice},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05655-5}
}
EUVIMED